Drugs and Devices

U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase)

On Jan. 17, the U.S. Food and Drug Administration (FA) approved Voraxaze (glucarpidase) to treat patients with toxic blood levels of methotrexate because of renal failure. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Newsletter Subscribe

  • This field is for validation purposes and should be left unchanged.

Test Your Nursing Knowledge

Answer this interactive quiz to be entered to win a gift card.

  • This field is for validation purposes and should be left unchanged.

Insights Blog

Today’s News in Nursing

Shares